AVALO THERAPEUTICS, INC. (AVTX)

SEC filing

AVALO THERAPEUTICS, INC.

AVTX · CIK 1534120

4 · Aug 19, 2026 · Chief Medical Officer Doyle Mittie sold 1,000 shares at $20.00/share ($20,000); exercised options for 2,000 shares

Chief Medical Officer Doyle Mittie sold 1,000 shares at $20.00/share ($20,000); exercised options for 2,000 shares

xslF345X06/form4-08192026_040810.xml

xslF345X06/form4-08192026_040810.xmlSEC.gov

Graphics and non-inline formats (not embedded below).